Skip to main content
Erschienen in: Clinical Autonomic Research 2/2024

30.03.2024 | Letter to the Editor

Supine hypertension is longitudinally associated with verbal memory decline in Parkinson disease

verfasst von: Cameron Miller-Patterson, Jesse Y. Hsu, Matthew J. Barrett, Leslie J. Cloud, Brian D. Berman, Thomas C. Chelimsky

Erschienen in: Clinical Autonomic Research | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Excerpt

Parkinson disease (PD) is associated with cognitive decline, for which there are no preventative therapeutics [1]. While multifactorial [1], cognitive decline in PD is associated with cardiovascular autonomic dysfunction, including orthostatic hypotension (OH) and supine hypertension (SH). This association may reflect a particular phenotype with more diffuse Lewy body pathology [2]. Alternatively, cardiovascular autonomic dysfunction may contribute to cognitive decline via hypoxia-associated atrophy or white matter disease [35]. If the latter, treatment of OH and/or SH may reduce cognitive decline. However, no studies have evaluated the contributions of OH and SH to cognitive decline longitudinally. Clarifying whether OH, SH, or both drive cognitive decline is critical for determining which should be treated, even if asymptomatic, since either may be a confounder and the treatment of one may worsen the other. Here, we have evaluated whether OH and/or SH is independently associated with cognitive decline in PD across different cognitive domains for up to 9 years to inform potential interventional studies evaluating whether cardiovascular autonomic dysfunction treatment reduces cognitive decline. …
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Aarsland D, Batzu L, Halliday GM, Geurtsen GJ, Ballard C, Ray Chaudhuri K, Weintraub D (2021) Parkinson disease-associated cognitive impairment. Nat Rev Dis Primers 7(1):47CrossRefPubMed Aarsland D, Batzu L, Halliday GM, Geurtsen GJ, Ballard C, Ray Chaudhuri K, Weintraub D (2021) Parkinson disease-associated cognitive impairment. Nat Rev Dis Primers 7(1):47CrossRefPubMed
2.
Zurück zum Zitat Fereshtehnejad SM, Romenets SR, Anang JB, Latreille V, Gagnon JF, Postuma RB (2015) New clinical subtypes of Parkinson disease and their longitudinal progression: a prospective cohort comparison with other phenotypes. JAMA Neurol 72(8):863–873CrossRefPubMed Fereshtehnejad SM, Romenets SR, Anang JB, Latreille V, Gagnon JF, Postuma RB (2015) New clinical subtypes of Parkinson disease and their longitudinal progression: a prospective cohort comparison with other phenotypes. JAMA Neurol 72(8):863–873CrossRefPubMed
3.
Zurück zum Zitat Kim JS, Oh YS, Lee KS, Kim YI, Yang DW, Goldstein DS (2012) Association of cognitive dysfunction with neurocirculatory abnormalities in early Parkinson disease. Neurology 79(13):1323–1331CrossRefPubMedPubMedCentral Kim JS, Oh YS, Lee KS, Kim YI, Yang DW, Goldstein DS (2012) Association of cognitive dysfunction with neurocirculatory abnormalities in early Parkinson disease. Neurology 79(13):1323–1331CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Pilotto A, Romagnolo A, Scalvini A, Masellis M, Shimo Y, Bonanni L, Camicioli R, Wang LL, Dwivedi AK, Longardner K et al (2021) Association of orthostatic hypotension with cerebral atrophy in patients with Lewy body disorders. Neurology 97(8):e814–e824CrossRefPubMedPubMedCentral Pilotto A, Romagnolo A, Scalvini A, Masellis M, Shimo Y, Bonanni L, Camicioli R, Wang LL, Dwivedi AK, Longardner K et al (2021) Association of orthostatic hypotension with cerebral atrophy in patients with Lewy body disorders. Neurology 97(8):e814–e824CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Ruiz Barrio I, Miki Y, Jaunmuktane ZT, Warner T, De Pablo-Fernandez E (2023) Association between orthostatic hypotension and dementia in patients with Parkinson disease and multiple system atrophy. Neurology 100(10):e998–e1008CrossRefPubMedPubMedCentral Ruiz Barrio I, Miki Y, Jaunmuktane ZT, Warner T, De Pablo-Fernandez E (2023) Association between orthostatic hypotension and dementia in patients with Parkinson disease and multiple system atrophy. Neurology 100(10):e998–e1008CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Marek K, Jennings D, Lasch S, Siderowf A, Tanner C, Simuni T, Coffey C, Kieburtz K, Flagg E, Chowdhury S, Poewe W (2011) Parkinson progression marker I: the Parkinson progression marker initiative (PPMI). Prog Neurobiol 95(4):629–635CrossRefPubMedCentral Marek K, Jennings D, Lasch S, Siderowf A, Tanner C, Simuni T, Coffey C, Kieburtz K, Flagg E, Chowdhury S, Poewe W (2011) Parkinson progression marker I: the Parkinson progression marker initiative (PPMI). Prog Neurobiol 95(4):629–635CrossRefPubMedCentral
7.
Zurück zum Zitat Litvan I, Goldman JG, Troster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH et al (2012) Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Mov Disord 27(3):349–356CrossRefPubMedPubMedCentral Litvan I, Goldman JG, Troster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH et al (2012) Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Mov Disord 27(3):349–356CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, Cheshire WP, Chelimsky T, Cortelli P, Gibbons CH et al (2011) Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res 21(2):69–72CrossRefPubMed Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, Cheshire WP, Chelimsky T, Cortelli P, Gibbons CH et al (2011) Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res 21(2):69–72CrossRefPubMed
9.
Zurück zum Zitat Fanciulli A, Jordan J, Biaggioni I, Calandra-Buonaura G, Cheshire WP, Cortelli P, Eschlboeck S, Grassi G, Hilz MJ, Kaufmann H et al (2018) Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS): endorsed by the European Academy of Neurology (EAN) and the European Society of Hypertension (ESH). Clin Auton Res 28(4):355–362CrossRefPubMedPubMedCentral Fanciulli A, Jordan J, Biaggioni I, Calandra-Buonaura G, Cheshire WP, Cortelli P, Eschlboeck S, Grassi G, Hilz MJ, Kaufmann H et al (2018) Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS): endorsed by the European Academy of Neurology (EAN) and the European Society of Hypertension (ESH). Clin Auton Res 28(4):355–362CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R et al (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23(15):2129–2170CrossRefPubMed Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R et al (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23(15):2129–2170CrossRefPubMed
11.
Zurück zum Zitat Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25(15):2649–2653CrossRefPubMed Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25(15):2649–2653CrossRefPubMed
12.
Zurück zum Zitat Visser M, Marinus J, Stiggelbout AM, Van Hilten JJ (2004) Assessment of autonomic dysfunction in Parkinson’s disease: the SCOPA-AUT. Mov Disord 19(11):1306–1312CrossRefPubMed Visser M, Marinus J, Stiggelbout AM, Van Hilten JJ (2004) Assessment of autonomic dysfunction in Parkinson’s disease: the SCOPA-AUT. Mov Disord 19(11):1306–1312CrossRefPubMed
13.
Zurück zum Zitat Stiasny-Kolster K, Mayer G, Schafer S, Moller JC, Heinzel-Gutenbrunner M, Oertel WH (2007) The REM sleep behavior disorder screening questionnaire–a new diagnostic instrument. Mov Disord 22(16):2386–2393CrossRefPubMed Stiasny-Kolster K, Mayer G, Schafer S, Moller JC, Heinzel-Gutenbrunner M, Oertel WH (2007) The REM sleep behavior disorder screening questionnaire–a new diagnostic instrument. Mov Disord 22(16):2386–2393CrossRefPubMed
14.
Zurück zum Zitat Vanderploeg RD, Schinka JA, Jones T, Small BJ, Graves AB, Mortimer JA (2000) Elderly norms for the Hopkins verbal learning test-revised. Clin Neuropsychol 14(3):318–324CrossRefPubMed Vanderploeg RD, Schinka JA, Jones T, Small BJ, Graves AB, Mortimer JA (2000) Elderly norms for the Hopkins verbal learning test-revised. Clin Neuropsychol 14(3):318–324CrossRefPubMed
15.
Metadaten
Titel
Supine hypertension is longitudinally associated with verbal memory decline in Parkinson disease
verfasst von
Cameron Miller-Patterson
Jesse Y. Hsu
Matthew J. Barrett
Leslie J. Cloud
Brian D. Berman
Thomas C. Chelimsky
Publikationsdatum
30.03.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Autonomic Research / Ausgabe 2/2024
Print ISSN: 0959-9851
Elektronische ISSN: 1619-1560
DOI
https://doi.org/10.1007/s10286-024-01026-3

Weitere Artikel der Ausgabe 2/2024

Clinical Autonomic Research 2/2024 Zur Ausgabe

Neu in den Fachgebieten Neurologie und Psychiatrie

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.